Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome
Journal of the American Society of Nephrology, 2019-12, Vol.30 (12), p.2449-2463 [Peer Reviewed Journal]Copyright © 2019 by the American Society of Nephrology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2019 by the American Society of Nephrology 2019 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/ASN.2019040331 ;PMID: 31575699
Full text available